Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Birth Control Methods01:22

Birth Control Methods

232
Vasectomy is a surgical form of male sterilization that involves severing and sealing the vasa deferentia, preventing sperm from mixing with semen during ejaculation. Because a vasectomy does not impact the testes' ability to produce testosterone, hormone levels, libido, and sexual function generally remain unchanged. While vasectomy is highly effective in preventing pregnancy, with a success rate near 99.85%, rare cases of recanalization (spontaneous reconnection) can occur. Although...
232
Infertility in Males01:23

Infertility in Males

260
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
260
Disorders of the Male Reproductive System01:20

Disorders of the Male Reproductive System

395
Men's health issues are increasingly recognized as significant, with several conditions posing common threats. Among these, testicular cancer is especially prevalent in younger men, particularly those aged 20 to 35 years. The disease often manifests as a painless mass in the testicles, sometimes accompanied by a sensation of heaviness or a dull ache.
Prostate disorders are another major concern. These conditions can impair urinary flow due to the prostate's location around the urethra....
395
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

3.0K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
3.0K
Spermatogenesis01:41

Spermatogenesis

102.4K
Spermatogenesis is the process by which haploid sperm cells are produced in the male testes. It starts with stem cells located close to the outer rim of seminiferous tubules. These spermatogonial stem cells divide asymmetrically to give rise to additional stem cells (meaning that these structures “self-renew”), as well as sperm progenitors, called spermatocytes. Importantly, this method of asymmetric mitotic division maintains a population of spermatogonial stem cells in the male...
102.4K
Intracellular Hormone Receptors01:08

Intracellular Hormone Receptors

55.2K
Lipid-soluble hormones diffuse across the plasma and nuclear membrane of target cells to bind to their specific intracellular receptors. These receptors act as transcription factors that regulate gene expression and protein synthesis in the target cell
55.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Syntheses of YCT-529: Net [3 + 2] Cycloaddition and One-Pot Bromination-Suzuki-Miyaura Coupling Strategies.

The Journal of organic chemistryĀ·2026
Same author

Pharmacokinetic and pharmacological characterization of novel agmatine-based antihyperalgesic compounds.

The Journal of pharmacology and experimental therapeuticsĀ·2026
Same author

Development of TSSK1 and TSSK2 Targeted Degraders Reveals Sperm Machinery for Protein Degradation and Potential for Nonhormonal Male Contraception.

Journal of medicinal chemistryĀ·2026
Same author

LKB1 Loss Sensitizes Lung Tumor Spheres to Mitomet-Induced Ferroptosis, and These Effects are Enhanced by mTOR Inhibition.

Molecular carcinogenesisĀ·2026
Same author

Development of a Second-Generation RARĪ± Selective Antagonist as an Orally Bioavailable, Effective, Safe, and Reversible Male Contraceptive.

Journal of medicinal chemistryĀ·2026
Same author

Structural Basis for BD1-Preferring 2,4-Disubstituted Pyrimidine BRDT Inhibitors.

Journal of medicinal chemistryĀ·2026

Related Experiment Video

Updated: Jun 25, 2025

Mouse Round Spermatid Injection
08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

716

An emerging target for male contraception.

Jerrett Holdaway1, Gunda I Georg1

  • 1University of Minnesota Twin Cities, Minneapolis, MN, USA.

Science (New York, N.Y.)
|May 23, 2024
PubMed
Summary

Researchers identified a novel inhibitor for a nonhormonal target using a DNA-encoded chemical library. This approach accelerates the discovery of new therapeutic agents by screening vast chemical spaces.

Area of Science:

  • Medicinal Chemistry
  • Chemical Biology
  • Drug Discovery

Background:

  • Traditional drug discovery methods face challenges in identifying inhibitors for nonhormonal targets.
  • DNA-encoded chemical libraries (DELs) offer a powerful platform for high-throughput screening of vast molecular diversity.

Discussion:

  • This study demonstrates the successful application of a DNA-encoded chemical library to identify a potent inhibitor against a specific nonhormonal target.
  • The identified inhibitor represents a promising starting point for further optimization and development of novel therapeutics.
  • The DEL approach facilitates rapid hit identification and provides valuable structure-activity relationship insights.

Key Insights:

  • A novel inhibitor for a nonhormonal target was discovered using DNA-encoded chemistry.

More Related Videos

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:27

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

724
Medium-throughput Screening Assays for Assessment of Effects on Ca2+-Signaling and Acrosome Reaction in Human Sperm
05:44

Medium-throughput Screening Assays for Assessment of Effects on Ca2+-Signaling and Acrosome Reaction in Human Sperm

Published on: March 1, 2019

8.2K

Related Experiment Videos

Last Updated: Jun 25, 2025

Mouse Round Spermatid Injection
08:41

Mouse Round Spermatid Injection

Published on: January 26, 2024

716
Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies
06:27

Establishment of Rat Models Mimicking Gender-affirming Hormone Therapies

Published on: January 10, 2025

724
Medium-throughput Screening Assays for Assessment of Effects on Ca2+-Signaling and Acrosome Reaction in Human Sperm
05:44

Medium-throughput Screening Assays for Assessment of Effects on Ca2+-Signaling and Acrosome Reaction in Human Sperm

Published on: March 1, 2019

8.2K
  • The study validates the efficacy of DELs in identifying inhibitors for challenging biological targets.
  • The identified compound shows potential for therapeutic intervention.

    • Outlook:

    • Further preclinical studies are warranted to evaluate the safety and efficacy of the identified inhibitor.
    • The methodology can be extended to discover inhibitors for other nonhormonal targets, broadening therapeutic applications.
    • This work paves the way for accelerated development of new drugs targeting previously undruggable proteins.